Papers

20

Total Citations

305

H-Index

8

About

Dr. Masayuki Kojima is a pioneering hepatobiliary and pancreatic surgeon whose research has fundamentally shaped the modern practice of minimally invasive liver and pancreatic surgery. His work centers on comparing the safety, efficacy, and technical nuances of robotic versus laparoscopic approaches for complex procedures. Dr. Kojima’s landmark 2022 study, a propensity score-matched analysis of over 3,800 major hepatectomies, demonstrated that robotic right and extended right hepatectomies are safe and feasible, achieving comparable outcomes to laparoscopic techniques while offering potential advantages in complex dissections. This work, cited over 120 times, is complemented by his international multicenter studies on open conversion risk factors, which provide critical decision-making frameworks for surgeons. He has also made significant contributions to the management of hepatocellular carcinoma in cirrhotic patients, showing that minimally invasive anatomic resections using the extrahepatic Glissonian approach yield excellent perioperative outcomes. With over 250 total citations, Dr. Kojima’s research has directly influenced clinical guidelines and training curricula worldwide, establishing him as a leading authority in the safe expansion of robotic hepatobiliary surgery.

Research Focus

Key Achievements

8
H-Index
20
Papers
305
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Propensity Score–Matched Analysis Comparing Robotic and Laparoscopic Right and Extended Right Hepatectomy
120 citations · 2022
📈 Most Prolific Year: 2023 (9 Papers)
🤝 Key Collaborators: 167
🏛 Institutions: Fujita Health University, Oslo University Hospital, Fujita Health University Hospital

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago